PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteIllumina announced BioInsight Platform on October 14, 2026, as a unified software environment for genomic and multiomic analysis. It brings analysis applications, purpose-built artificial intelligence, and curated biological datasets behind one sign-on, with usage-based BioInsight Credits replacing traditional annual subscriptions.
What BioInsight Platform is
BioInsight Platform is Illumina’s software-and-data environment for turning large genomic and multiomic datasets into biological evidence. It is not a new sequencing instrument. Instead, it brings several analysis products, AI capabilities, and reusable datasets into one environment so researchers can move from raw or processed data to interpretation without managing each capability as a separate service.
As an Amazon Associate I earn from qualifying purchases.
Illumina says the platform is intended for researchers, healthcare organizations, and biopharmaceutical companies working on drug-target discovery, disease biology, precision medicine, variant interpretation, and related questions. Access is managed through a single sign-on, while the commercial model is based on consumption rather than a conventional annual software subscription.
What the platform brings together
The launch consolidates an expanding informatics portfolio. Illumina identifies the following components as part of the BioInsight environment:
#1 Best Overall
- TOP-SELLING CONSUMER DNA TEST: From your origins in over 3,600+ places around the world to the most connections to living relatives, no other DNA test kit delivers an experience as unique and interactive as AncestryDNA.
- YOUR DATA, YOUR CONTROL: We give you full control over your genetic information. You decide what to share, and with whom.
- DNA + TRAITS: Ever wondered where your freckles came from, or why you hate cilantro? AncestryDNA + Traits lets you discover 75+ genetic traits, allowing you to explore how your genes might have influenced a range of appearance, sensory, performance, nutrient, and other personal characteristics.
- A FEW SIMPLE STEPS: Simply activate your DNA kit online and return your saliva sample in the prepaid package to our state-of-the-art lab. Your results will be available online in roughly six weeks.
- ORIGINS AND INHERITANCE: AncestryDNA is the only DNA test that can show your origins results, DNA matches, and traits by each side of the family, without your parents taking a DNA test.
| Component | Documented role in the platform |
|---|---|
| DRAGEN | Analysis software included in the unified portfolio for genomic data processing. |
| Emedgene | Named as an integrated BioInsight informatics capability. |
| Connected Multiomics | Cloud-based analysis and visualization for multiomic and multimodal data at scale. |
| BioInsight Platform Core | The core environment that provides the common platform experience and access model. |
| BaseSpace | Provides sequencer-to-cloud connectivity and can trigger downstream DRAGEN analysis without manual uploads, file transfers, or scripts. |
| BioInsight Data | Curated, harmonized, annotated datasets spanning oncology, rare disease, population health, and multiomics. |
The practical significance is workflow continuity. BaseSpace can move sequencing output into cloud analysis and start a DRAGEN workflow without a researcher manually moving files or writing a script. The data layer is designed for comparing studies, adding biological context to findings, and generating hypotheses from reusable datasets.
How BioInsight’s AI and data layers work together
AI for prioritization and prediction
Illumina’s BioInsight AI Lab develops models for variant-effect prediction, variant-effect prioritization, and biological foundation-model training. The launch specifically highlights SpliceAI2 for rare-disease research. These models are intended to help researchers focus on variants or signals most likely to have biological importance, rather than treating every output from a large sequencing study equally.
Curated data for context
BioInsight Data covers oncology, rare disease, population health, and multiomics. Illumina describes these resources as harmonized and annotated, which is meant to make results from different studies easier to compare and reuse. In a typical investigation, an analysis result can therefore be examined alongside curated biological evidence instead of being interpreted in isolation.
Recommended Free Tools
Rank #2
- TOP-SELLING CONSUMER DNA TEST: From your origins in over 3,600 places around the world to the most connections to living relatives, no other DNA test kit delivers an experience as unique and interactive as AncestryDNA.
- YOUR DATA, YOUR CONTROL: We give you full control over your genetic information. You decide what to share, and with whom.
- A FEW SIMPLE STEPS: Simply activate your DNA kit online and return your saliva sample in the prepaid package to our state-of-the-art lab. Your results will be available online in roughly six weeks.
- ORIGINS AND INHERITANCE: AncestryDNA provides more precise ancestral origins with greater geographic detail. Our innovative SideView technology takes your results even further by showing your origins and matches by parental side. *Some DNA features require an Ancestry subscription.
- BUILD YOUR FAMILY TREE: Combine what you learn from your DNA results with an Ancestry subscription and gain access to millions of family trees and the world's largest collection of online family history records. *Access to record collections varies depending on subscription level.
A shared environment instead of disconnected tools
The platform’s unifying feature is the combination of applications, models, and data under one identity and usage framework. That does not mean every workflow becomes automatic: organizations still need to select appropriate methods, validate findings, and govern access to sensitive datasets. BioInsight is intended to reduce the operational friction of stitching together separate analysis services.
Who can use it and what it costs
Illumina positions BioInsight for three broad customer groups:
- Researchers: teams studying disease mechanisms, rare variants, population patterns, or multiomic relationships.
- Healthcare organizations: groups working on clinical interpretation and precision-medicine workflows.
- Biopharma companies: organizations investigating drug targets, disease biology, and translational evidence.
Illumina has not published price levels for BioInsight Credits in the launch materials. It says credits replace traditional annual subscriptions and let customers pay for the capabilities and amount of use relevant to their projects while evaluating additional technologies. Illumina also directs prospective users to a free-trial signup.
Rank #3
- ABOUT THE TEST: The Genetrace DNA Paternity Test helps families conclusively determine if a man is the true father of a child.
- NO HIDDEN FEES: Kit includes all lab fees and sample return costs to test one (1) child and one (1) potential father.
- FAST RESULTS: Get secure, confidential results within 1-2 business days after testing begins. We'll keep you updated every step of the way.
- EASY SAMPLE COLLECTION: No needles, no blood, no doctors. Collect your samples with our easy-to-use mouth swabs, then return them to the lab with the provided prepaid return envelope. It's quick, easy & painless.
- ACCURATE & RELIABLE: Up to 27 genetic markers analyzed for over 99.999% accuracy. All tests performed TWICE in our AABB, ISO 17025 & CLIA accredited laboratory.
Because the price of a credit, the rate at which individual analyses consume credits, and enterprise-contract terms were not disclosed, prospective customers should request a usage schedule before budgeting. Important questions include whether storage, model execution, data access, and support consume credits separately; how credits expire; and how costs change when a pilot becomes a production workflow.
Is BioInsight an instrument, a cloud service, or an AI product?
It is best understood as a cloud-oriented software and data platform that incorporates AI. BioInsight does not replace a sequencer. It connects sequencing output and other genomic or multiomic data to analysis applications, models, and curated datasets. BaseSpace supplies the sequencer-to-cloud connection, while products such as DRAGEN and Connected Multiomics perform documented analysis functions within the broader portfolio.
Connected Multiomics itself was released in January 2026 as a cloud platform for analyzing and visualizing multiomic and multimodal data at scale. Illumina said that product followed a year of early access involving 40 users. Its inclusion in BioInsight gives that capability a common home alongside the rest of the portfolio.
Rank #4
- MAP YOUR ORIGINS ACROSS 5,000+ REGIONS: Ancestry Composition breaks down your ethnicity across 5,000+ geographic regions worldwide, the most detailed ancestry breakdown of any consumer DNA service. Ancestry Timeline estimates how many generations ago your most recent ancestor from each population lived.
- FIND LIVING RELATIVES: Opt in to DNA Relatives to see up to 1,500 people in the 23andMe database who share DNA with you, from close family to distant cousins, and message them directly. Your Family Tree builds itself automatically based on your DNA.
- DISCOVER WHAT MAKES YOU UNIQUE: See how your DNA may influence physical features, sensory preferences, and habits across 30+ traits, including cilantro taste aversion to hair texture to deep sleep.
- TRACE ANCIENT MIGRATIONS: Maternal and Paternal Haplogroup reports follow your ancestors' migration paths across continents over thousands of years (paternal haplogroup requires a Y chromosome). Find out how much of your ancestry can be traced back to the Neanderthals.
- PRIVATE BY DESIGN: Your DNA data is encrypted, protected, and always under your control. Enhanced security measures are implemented to keep your information safe. Subject to 23andMe’s Terms of Service and Privacy Statement at 23andMe online.
Why Illumina launched BioInsight
Illumina created the BioInsight business in 2025 as genomic projects grew larger and more multimodal, making interpretation more difficult than simply generating sequence data. The company says its focus includes large national and industry data projects, scalable multimodal analysis, secure access to private research data, and partnerships for developing AI tools.
Rami Mehio, Illumina’s senior vice president and general manager of BioInsight, described the platform as “one simple place” for customers to access Illumina’s software, AI, and data offerings. He also said additional capabilities are planned, so the initial product should be viewed as a growing environment rather than a fixed list of tools.
What is established—and what still needs validation
The launch establishes the platform’s components, intended users, credit-based commercial model, and stated use cases. It does not provide independent head-to-head benchmarks against other genomics platforms, published customer-outcome studies, or a detailed price card.
Best Value
- About HomePaternity: This DNA test will conclusively determine if a man is the biological father of a child using a simple at-home kit including cheek swabs from the father and child.
- Fast Results: Your kit includes Overnight FedEx return to the lab and results will be available within 1-2 days after your sample arrives, in our secure online portal.
- Over 99.999% Confidence: With up to 34 genetic markers examined, we confirm paternity with the highest accuracy, typically 99.999%+. Tests are run twice in our lab, which has obtained over 6 certifications.
- Easy Sample Collection: Collect your samples with mouth swabs, then return in the pre-paid Overnight mailer. Includes testing for 1 child and 1 possible father; can add more participants after kit registration.
- Internal Lab: With over 25 years of experience and over 20 million tests performed, we don’t use third-party labs.
Illumina product pages make two notable performance claims: DRAGEN can analyze a 30× whole genome in under 25 minutes, and genetically supported drug targets have 2.6 times higher approval rates. Those figures are Illumina’s own product-page claims, not independent measurements supplied with the BioInsight announcement. Their relevance depends on the exact workflow, hardware or cloud configuration, dataset, and comparison used.
Organizations evaluating BioInsight should therefore validate:
- reproducibility and audit trails for their own pipelines;
- model explainability, validation datasets, and error handling for AI-generated priorities;
- data provenance, permissions, retention, and segregation for private studies;
- interoperability with existing sequencers, file formats, laboratory systems, and computational pipelines;
- credit consumption and total cost at pilot, routine, and large-cohort scale.
What the October 2026 launch means
BioInsight Platform gives Illumina a single commercial and technical umbrella for sequencing-connected analysis, multiomic visualization, AI-assisted interpretation, and curated biological data. Its main change for customers is not a new instrument generation but a different way to access informatics capabilities: one environment, one sign-on, and usage-based credits. Whether that model delivers better economics or faster scientific decisions will depend on each organization’s workloads and validation results, which Illumina has not independently demonstrated in the launch announcement.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
